The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Cu2MoS4 Nanozyme with NIR‐II Light Enhanced Catalytic Activity for Efficient Eradication of Multidrug‐Resistant Bacteria
Abstract
Nanozymes with unique enzyme‐like catalytic properties and versatile functionalities are particularly attractive for the treatment of bacterial infections, especially for combating drug‐resistant bacteria. However, inherently low catalytic activity significantly limits their antibacterial performance. Herein, a new near‐infrared II (NIR‐II) light responsive nanozyme (Cu 2 MoS 4 nanoplates, CMS NPs) is developed for efficient eradication of multidrug‐resistant (MDR) bacteria. CMS NPs with intrinsic dual enzyme‐like property can generate reactive oxygen species (ROS) by catalysis. Importantly, CMS NPs show NIR‐II light enhanced oxidase‐ and peroxidase‐like catalytic activities to improve ROS generation for highly efficient killing of bacteria. In vitro results demonstrate that CMS NPs (40 µg mL−1) achieve rapid killing of 8 log MDR Escherichia coli and 6 log MDR Staphylococcus aureus (S. aureus) under NIR‐II light irradiation (1064 nm, 1 W cm−2) in 10 min. Moreover, CMS NPs exhibit excellent therapeutic efficacy of MDR S. aureus infection in vivo as well as negligible toxicity to cells and animals, indicating their potential use as antibacterial agents. This work provides a novel antibacterial strategy by combining the catalytic generation of ROS and NIR‐II photothermal effect of nanozymes for efficient treatment of MDR bacteria‐related infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles
Gao, L., Zhuang, J., Nie, L., Zhang, J., Zhang, Y., Gu, N., Wang, T., Feng, J., Yang, D., Perrett, S., et al. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.260 · Cited by 7,483
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
Fang, F. C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1004 · Cited by 1,676
He, S., Song, J., Qu, J., & Cheng, Z. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00234g · Cited by 1,021
Cited by
An overview of the use of nanozymes in antibacterial applications
Mei, L., Zhu, S., Liu, Y., Yin, W., Gu, Z., & Zhao, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129431 · Cited by 369
Wang, X., Shi, Q., Zha, Z., Zhu, D., Zheng, L., Shi, L., Wei, X., Lian, L., Wu, K., & Cheng, L. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.024 · Cited by 353
Nanozybiotics: advancing antimicrobial strategies through biomimetic mechanisms
Zhou, C., Wang, Q., Cao, H., Jiang, J., & Gao, L. (2024) · Advanced Materials · doi:10.1002/adma.202403362 · Cited by 114
Metadata
- Authors
- Shan, J., Yang, K., Xiu, W., Qiu, Q., Dai, S., Yuwen, L., Weng, L., Teng, Z., & Wang, L.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2020-09-06
- Volume
- 16
- Issue
- 40
- Pages
- e2001099-e2001099
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W3083703349
- Cited by
- 181
- References
- 5
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cu2MoS4 Nanozyme with NIR‐II Light Enhanced Catalytic Activity for Efficient Eradication of Multidrug‐Resistant Bacteria. https://app.cochat.ai/papers/10.1002/smll.202001099
- The paper
- Shan, J., Yang, K., Xiu, W., Qiu, Q., Dai, S., Yuwen, L., Weng, L., Teng, Z., & Wang, L. (2020). Cu2MoS4 Nanozyme with NIR‐II Light Enhanced Catalytic Activity for Efficient Eradication of Multidrug‐Resistant Bacteria. Small. https://doi.org/10.1002/smll.202001099
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.